HRT Financial’s Serina Therapeutics SER Stock Holding History

HRT Financial’s Portfolio SER Stock Details SER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-387	Closed	-$26K	–	1739
2019 Q3	$26K	Buy	+387	New	+$36.7K	﹤0.01%	1327

Other funds holding SER

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PGP

Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return

Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

HRT Financial's SER Position: Q4 2019 in Review

HRT Financial sold out of Serina Therapeutics (SER) in Q4 2019, closing a stake of 387 shares — an estimated $26K sold.

HRT Financial first reported a position in SER in Q3 2019 and held it in 1 quarter. The position peaked at $26K in Q3 2019. 51 funds tracked by Wall St. Rank hold SER as of Q4 2019.

HRT Financial reported no remaining Serina Therapeutics position as of Q4 2019 after selling out during the quarter.
HRT Financial sold 387 Serina Therapeutics shares in Q4 2019, an estimated $26K.
HRT Financial first reported a position in Serina Therapeutics in Q3 2019 and held it in 1 quarter.
HRT Financial's Serina Therapeutics position peaked at $26K in Q3 2019.
51 funds tracked by Wall St. Rank held Serina Therapeutics as of Q4 2019.

Based on HRT Financial's 13F filing for Q4 2019, filed 14 Feb 2020.